NOVO.B.DK

281.9

+4.76%↑

GMAB.DK

1,615

+0.28%↑

HLUNB.DK

44.5

+3.92%↑

ZEAL.DK

282.7

+0.35%↑

AMBUB.DK

64.05

-1.23%↓

NOVO.B.DK

281.9

+4.76%↑

GMAB.DK

1,615

+0.28%↑

HLUNB.DK

44.5

+3.92%↑

ZEAL.DK

282.7

+0.35%↑

AMBUB.DK

64.05

-1.23%↓

NOVO.B.DK

281.9

+4.76%↑

GMAB.DK

1,615

+0.28%↑

HLUNB.DK

44.5

+3.92%↑

ZEAL.DK

282.7

+0.35%↑

AMBUB.DK

64.05

-1.23%↓

NOVO.B.DK

281.9

+4.76%↑

GMAB.DK

1,615

+0.28%↑

HLUNB.DK

44.5

+3.92%↑

ZEAL.DK

282.7

+0.35%↑

AMBUB.DK

64.05

-1.23%↓

NOVO.B.DK

281.9

+4.76%↑

GMAB.DK

1,615

+0.28%↑

HLUNB.DK

44.5

+3.92%↑

ZEAL.DK

282.7

+0.35%↑

AMBUB.DK

64.05

-1.23%↓

Accueil・Liste d'Actions・Coloplast A-S (Class B)

Search

Coloplast A-S (Class B)

Fermé

384.4 -0.88

Résumé

Variation du prix de l'action

24h

Actuel

Min

377.8

Max

387.7

Chiffres clés
By Trading Economics
Revenu	-2.4B -971M
Ventes	41M 7.1B
P/E Moyenne du Secteur	41.674 49.052
BPA	-0.16
Rendement du dividende	5.99
Marge bénéficiaire	-13.707
Employés	17,083
EBITDA	2.8B 5.1B

Recommandations
By TipRanks
Recommandations	Neutre
Prévisions sur 12 Mois	+11.86% upside

Dividendes
By Dow Jones
Rendement du dividende Moyenne du Secteur	5.99% 2.36%

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-2.7B 88B
Ouverture précédente	385.28
Clôture précédente	384.4

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

10 juin 2026, 23:36 UTC

Résultats

Correction to Oracle Reports Higher 4Q Profit Article

10 juin 2026, 23:19 UTC

Actions en Tendance

Stocks to Watch: Oracle, Oxford Industries, Humacyte, PureCycle Technologies

10 juin 2026, 23:09 UTC

Principaux Mouvements du Marché

PureCycle Technologies Slides on Offerings of Stock and Convertible Notes

10 juin 2026, 23:04 UTC

Résultats

Oracle Reports Higher 4Q Profit on Surging Cloud Revenue -- Update

10 juin 2026, 20:44 UTC

Principaux Mouvements du Marché

Caterpillar Raises Quarterly Dividend 8%

10 juin 2026, 23:49 UTC

Acquisitions, Fusions, Rachats

Elliott: Northern Star Should Take No Options Off The Table

10 juin 2026, 23:48 UTC

Acquisitions, Fusions, Rachats

Elliott: Reiterates Call For Formal Strategic Review of Northern Star

10 juin 2026, 23:48 UTC

Acquisitions, Fusions, Rachats

Elliott: Northern Star Board Must Be Substantially Strengthened Beyond 1 Additional Director

10 juin 2026, 23:47 UTC

Market Talk

Nintendo's Stock Recovery Likely Deferred Without Mario Game -- Market Talk

10 juin 2026, 23:47 UTC

Acquisitions, Fusions, Rachats

Elliott: Board Letter Indicates It Doesn't Understand Magnitude of Change Required

10 juin 2026, 23:46 UTC

Acquisitions, Fusions, Rachats

Elliott Investment Management: Northern Star Letter Validates Investment Thesis

10 juin 2026, 23:38 UTC

Market Talk

Global Equities Roundup: Market Talk

10 juin 2026, 23:38 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10 juin 2026, 23:38 UTC

Market Talk

Nikkei Likely to Fall on Renewed Concerns About Iran Conflict -- Market Talk

10 juin 2026, 23:32 UTC

Market Talk

Oil Rises Amid Escalating Supply-Disruption Fears -- Market Talk

10 juin 2026, 23:20 UTC

Market Talk

Wesfarmers's Bunnings Business Looks Resilient to Macro Headwinds -- Market Talk

10 juin 2026, 22:05 UTC

Market Talk

Correction to Bank of Canada Stays on Hold Market Talk

10 juin 2026, 21:57 UTC

Résultats

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 juin 2026, 21:52 UTC

Résultats

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 juin 2026, 21:35 UTC

Résultats

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 juin 2026, 21:22 UTC

Résultats

Oracle Stock Slides on Increased Capital Spending -- WSJ

10 juin 2026, 20:50 UTC

Market Talk

Résultats

Tech, Media & Telecom Roundup: Market Talk

10 juin 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

10 juin 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10 juin 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 juin 2026, 20:39 UTC

Market Talk

Résultats

Oracle Needs to Raise Less Capital to Fund Data-Center Buildout -- Market Talk

10 juin 2026, 20:34 UTC

Résultats

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 juin 2026, 20:33 UTC

Résultats

This 'Amazon for Travel' Firm Beat Earnings Expectations. The Stock Is Soaring. -- Barrons.com

10 juin 2026, 20:33 UTC

Market Talk

Résultats

Global Equities Roundup: Market Talk

10 juin 2026, 20:33 UTC

Market Talk

Résultats

Oracle Health Expected to Grow Double-Digits This Fiscal Year -- Market Talk

Comparaison

Variation de prix

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK 11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Basé sur 8 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Autres valeurs du secteur

NOVO.B.DK

Novo Nordisk A-S (Class B)

281.9

GMAB.DK

Genmab A-S

1,615

HLUNB.DK

H Lundbeck A-S

44.5

ZEAL.DK

Zealand Pharma A-S

282.7

AMBUB.DK

Ambu A-S

64.05

Live chat